Education
About Us
Working with TipRanks
Follow Us
Bioventus (BVS)
NASDAQ:BVS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 573.28M | $ 512.35M | $ 512.12M | $ 430.90M | $ 321.16M |
| Gross Profit | $ 388.23M | $ 328.19M | $ 331.08M | $ 302.71M | $ 233.52M |
| Operating Income | $ -11.98M | $ -81.72M | $ -167.23M | $ 12.06M | $ 21.24M |
| EBITDA | $ 39.22M | $ -23.07M | $ -121.61M | $ 45.48M | $ 54.31M |
| Net Income | $ -33.54M | $ -156.23M | $ -158.70M | $ 19.38M | $ 16.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 41.58M | $ 36.96M | $ 30.19M | $ 43.93M | $ 86.84M |
| Total Assets | $ 727.96M | $ 810.91M | $ 1.37B | $ 1.23B | $ 494.47M |
| Total Debt | $ 335.63M | $ 394.85M | $ 418.07M | $ 357.68M | $ 188.38M |
| Net Debt | $ 294.05M | $ 357.88M | $ 387.88M | $ 313.75M | $ 101.54M |
| Total Liabilities | $ 542.35M | $ 589.79M | $ 960.43M | $ 692.07M | $ 350.31M |
| Stockholders' Equity | $ 147.94M | $ 173.59M | $ 325.24M | $ 458.92M | $ 142.24M |
| Cash Flow | |||||
| Free Cash Flow | $ 37.79M | $ 7.98M | $ -15.02M | $ 2.10M | $ 51.13M |
| Operating Cash Flow | $ 38.80M | $ 15.34M | $ -13.54M | $ 22.99M | $ 71.80M |
| Investing Cash Flow | $ 22.96M | $ 15.81M | $ -116.44M | $ -283.76M | $ -20.50M |
| Financing Cash Flow | $ -54.58M | $ -26.65M | $ 62.08M | $ 273.37M | $ -29.57M |